In a lower socioeconomic Indonesian cohort, an increasing number of metabolic disorders correlated with higher cardiovascular risk scores and vascular age.
May support metabolic screening in similar low-resource cohorts; leaves open causal effects on vascular age.
ABSTRACTObjectives: The prevalence of hypertension, diabetes mellitus, dyslipidemia, and obesity in developing countries was high regardless the socioeconomicstatus, whereas the awareness and the control of these metabolic disorders were inadequate. The aim was to compare the cardiovascular risk basedon numbers of metabolic disorders among lower socioeconomic subjects.Methods: The study was done with the analytical cross-sectional method. The subjects were selected with cluster random sampling from four villages.We included the subjects of 30-65 years old and signed the informed consent but excluded the subjects who had not fasted for 8-10 hrs. We analyzedthe cardiovascular parameters among groups with ANOVA statistics, the difference between actual and heart vascular age (HVA) with paired t-test,and the change of six cardiovascular parameters with radar diagram.Results: The eligible subjects (n=222) comprised 0-4 metabolic disorders at 25.2%, 33.8%, 28.8%, 9.9%, and 1.8%, respectively; with age at50.1±9.0 years; body mass index (BMI) 24.1±4.8 kg/m2; blood pressure (BP) 141.6±23.4/82.8±11.7 mmHg; fasting blood sugar (FBS) 98.7±37.4 mg/dL;total and high-density lipoprotein cholesterol 201.0±37.9 and 55.1±12.7 mg/dL; Framingham score was 11.4±8.9% (referred as medium risk); thedifference between actual and HVA at 13.2±13.0 (p<0.05). Increasing metabolic disorders lead to higher BP, FBS, cholesterol, Framingham score, andthe difference between actual and HVA (p<0.05) excluding BMI in the four metabolic disorder subgroup.Conclusion: The subjects had the medium cardiovascular risk with above normal BMI, BP, and total cholesterol profiles. The average age, BP, FBS,cholesterol, Framingham score, and HVA were likely to increase equivalent to the numbers of metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Suhadi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: